| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. (AKBA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AKBA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.46M | $4.02M | - | |
| CFO | 320.0K | $371.2K | - | |
| Dir | 160.9K | $186.7K | - | |
| Dir | 129.5K | $150.2K | - | |
| VP | 119.0K | $138.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | Ostrowski Erik | SVP, CFO, Cbo &Treasurer | Sell | 41,314 | $3.67 | $151,622.38 | -7.6% | -25.5% | - | |
| Jun 9, 2025 | Malabre Richard C65 | SVP, Chief Accounting Officer | Sale+OE | 15,000 | $4.01 | $60,150.00 | -5.3% | -18.3% | - | |
| Jun 4, 2025 | Malabre Richard C65 | SVP, Chief Accounting Officer | Sell | 13,334 | $3.53 | $47,069.02 | -4.8% | -14.6% | - | |
| Mar 3, 2025 | Butler John P.61 | CEO And President | Sell | 46,409 | $1.83 | $84,928.47 | -1.8% | +80.6% | -32.5% | |
| Mar 3, 2025 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 7,144 | $1.83 | $13,073.52 | -0.9% | +80.6% | -32.5% | |
| Feb 3, 2025 | Butler John P.61 | CEO And President | Sell | 144,250 | $2.10 | $302,925.00 | -2.6% | +10.4% | -33.5% | |
| Feb 3, 2025 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 50,506 | $2.10 | $106,062.60 | -3.0% | +10.4% | -33.5% | |
| Feb 3, 2025 | Malabre Richard C65 | SVP, Chief Accounting Officer | Sell | 30,202 | $2.10 | $63,424.20 | -9.7% | +10.4% | -33.5% | |
| Feb 3, 2025 | Grund Nicholas | Chief Commercial Officer | Sell | 55,621 | $2.10 | $116,804.10 | -11.2% | +10.4% | -33.5% | |
| May 13, 2024 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 12,016 | $1.26 | $15,140.16 | -1.8% | -4.7% | +92.2% |